Cargando…
Androgen receptor agonist and antagonist reduce response of cytokine‐induced killer cells on prostate cancer cells
Despite many advances, prostate cancer (PCa) is still the second most frequently diagnosed cancer and fifth leading cause of cancer death in men worldwide. So far, the promising field of onco‐immunology has not yet provided a satisfactory treatment option for PCa. Here we show that the ex vivo expan...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538273/ https://www.ncbi.nlm.nih.gov/pubmed/37639523 http://dx.doi.org/10.1111/jcmm.17923 |